These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34507066)

  • 61. Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein.
    Pholcharee T; Oyen D; Torres JL; Flores-Garcia Y; Martin GM; González-Páez GE; Emerling D; Volkmuth W; Locke E; King CR; Zavala F; Ward AB; Wilson IA
    J Mol Biol; 2020 Feb; 432(4):1048-1063. PubMed ID: 31883801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
    Draper SJ; Biswas S; Spencer AJ; Remarque EJ; Capone S; Naddeo M; Dicks MD; Faber BW; de Cassan SC; Folgori A; Nicosia A; Gilbert SC; Hill AV
    J Immunol; 2010 Dec; 185(12):7583-95. PubMed ID: 21098232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Delay in the Licensing of Protozoal Vaccines: A Comparative History.
    Palatnik-de-Sousa CB; Nico D
    Front Immunol; 2020; 11():204. PubMed ID: 32210953
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
    Sedegah M; Hollingdale MR; Ganeshan H; Belmonte M; Huang J; Belmonte A; Inoue S; Velasco R; Hickey B; Teneza-Mora N; Lumsden J; Reyes S; Banania JG; Reyes A; Guzman I; Richie TL; Epstein JE; Villasante E
    PLoS One; 2021; 16(8):e0256396. PubMed ID: 34415964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.
    Rodríguez-Galán A; Salman AM; Bowyer G; Collins KA; Longley RJ; Brod F; Ulaszewska M; Ewer KJ; Janse CJ; Khan SM; Hafalla JC; Hill AVS; Spencer AJ
    Sci Rep; 2017 Dec; 7(1):17011. PubMed ID: 29209029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
    Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
    BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.
    Teixeira LH; Tararam CA; Lasaro MO; Camacho AG; Ersching J; Leal MT; Herrera S; Bruna-Romero O; Soares IS; Nussenzweig RS; Ertl HC; Nussenzweig V; Rodrigues MM
    Infect Immun; 2014 Feb; 82(2):793-807. PubMed ID: 24478093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
    Bang G; Prieur E; Roussilhon C; Druilhe P
    PLoS One; 2011; 6(12):e28165. PubMed ID: 22145028
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice.
    Rathore D; Kumar S; Lanar DE; McCutchan TF
    Mol Biochem Parasitol; 2001 Nov; 118(1):75-82. PubMed ID: 11704275
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity.
    Thai E; Costa G; Weyrich A; Murugan R; Oyen D; Flores-Garcia Y; Prieto K; Bosch A; Valleriani A; Wu NC; Pholcharee T; Scally SW; Wilson IA; Wardemann H; Julien JP; Levashina EA
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32790871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.
    Miura K; Zhou H; Muratova OV; Orcutt AC; Giersing B; Miller LH; Long CA
    Infect Immun; 2007 Dec; 75(12):5827-36. PubMed ID: 17923516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice.
    Zheng C; Xie P; Chen Y
    Parasitol Int; 2002 Mar; 51(1):1-7. PubMed ID: 11880222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
    Gregson AL; Oliveira G; Othoro C; Calvo-Calle JM; Thorton GB; Nardin E; Edelman R
    PLoS One; 2008 Feb; 3(2):e1556. PubMed ID: 18253503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda.
    Agwang C; Erume J; Okech B; Olobo J; Egwang TG
    Malar J; 2020 Oct; 19(1):361. PubMed ID: 33032613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
    Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
    PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice.
    Deal C; Balazs AB; Espinosa DA; Zavala F; Baltimore D; Ketner G
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12528-32. PubMed ID: 25114213
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
    Tine JA; Lanar DE; Smith DM; Wellde BT; Schultheiss P; Ware LA; Kauffman EB; Wirtz RA; De Taisne C; Hui GS; Chang SP; Church P; Hollingdale MR; Kaslow DC; Hoffman S; Guito KP; Ballou WR; Sadoff JC; Paoletti E
    Infect Immun; 1996 Sep; 64(9):3833-44. PubMed ID: 8751936
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria.
    Yadava A; Nurmukhambetova S; Pichugin AV; Lumsden JM
    J Infect Dis; 2012 May; 205(9):1456-63. PubMed ID: 22457289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.